https://theintercept.com/2020/12/15/cov ... ction-ppp/COVID-19 RELIEF DRAFT BILL PROVIDES $100 BILLION “DOUBLE-DIP” TAX DEDUCTION FOR THE WEALTHY
No stimulus checks, but big tax giveaways for well-connected business owners.
Lee Fang
December 15 2020, 3:06 p.m.
Maine State Police
https://www.pressherald.com/2020/12/15/ ... lice-unit/December 15 2020
Federal judge holds first hearing in lawsuit against secretive police unit
The Maine Attorney General's Office asked the judge to dismiss most claims in a whistleblower lawsuit that says a state trooper was retaliated against for objecting to police surveillance practices.
https://www.rt.com/news/509812-new-zeal ... iry-abuse/At least 250,000 children and adults physically and sexually abused in New Zealand’s state care institutions – inquiry
16 Dec, 2020 09:10
https://reason.com/2020/12/12/americas- ... lly-awful/FEDERAL PRISONS
America's Prison Food Is Still Criminally Awful
And COVID-19 has made it worse
BAYLEN LINNEKIN | 12.12.2020 8:30 AM
https://theintercept.com/2020/12/15/for ... port-army/FORT HOOD SOLDIERS HARBOR DOUBTS ABOUT ARMY’S ACCOUNTABILITY EFFORTS
A female sergeant said it was tragic that a soldier had to die before the Army took notice of sexual assault and harassment on base.
Melissa del Bosque
December 15 2020, 1:05 p.m.
https://theintercept.com/2020/12/16/int ... n-cabinet/AOC ON ENDING THE PELOSI ERA, BIDEN’S CORPORATE CABINET, AND THE BATTLE FOR MEDICARE FOR ALL
Rep. Alexandria Ocasio-Cortez and The American Prospect’s Executive Editor David Dayen are this week’s guests.
Intercepted
December 16 2020, 6:01 a.m.
https://www.rt.com/usa/509810-hunter-bi ... es-berges/HomeUSA News
Escapist exhibition: Hunter Biden reportedly planning ‘blow-art’ show in New York, despite ongoing DOJ investigation
16 Dec, 2020 09:53
https://www.sfgate.com/news/article/Pep ... 143426.phpPepper spray study is tainted
Jim Herron Zamora, OF THE EXAMINER STAFF
The pepper spray study was conducted in the late 1980s by FBI Special Agent Thomas W.W. Ward at the FBI academy in Virginia outside Washington, D.C. But Ward did not disclose at the time that he had accepted $57,000 from a pepper spray manufacturer that was laundered through a Florida company owned by his wife, Sheri.
https://www.youtube.com/watch?v=0k19cpPIlWQDr. William Pepper: Untold Truth on Martin Luther King's Assassination
Wednesday, December 16
Raid on COVID Whistleblower in Florida Shows the Need to Reform Overbroad Computer Crime Laws and the Risks of Over-Reliance on IP Addresses
Cindy Cohn, Electronic Frontier Foundation
The Border Patrol Is Cracking Down on Humanitarian Aid
Jessica Suriano, The Nation
The pandemic has taken surveillance of workers to the next level
Rachel Connolly, The Guardian
Biden Can, and Should, End America's Follies in Yemen
Daniel DePetris, InkStick
Tuesday, December 15
Assange Prosecution Is A Haunting Reminder Of My Espionage Act Case
Jeffrey Sterling, Shadowproof
The Case For a Pardon of Edward Snowden by President Trump
Glenn Greenwald, Glenn Greenwald Substack
New Orleans releases dozens of pages of emails on police use of facial recognition
Michael Isaac Stein, The Lens
Prisoners Are Setting Fires To Protest Pandemic Conditions
Keri Blakinger, The Marshall Project
Monday, December 14
GOP Lawmaker Claims 'Trump Is Listening to the Many of Us Who Are Urging Him to #PardonSnowden'
Jessica Corbett, Common Dreams
From Student Debtor to Soldier
Anna Attie, In These Times
Trump Supporters Protest Biden Election Win; Violence Erupts at Night
Michael M. Phillips, Alan Cullison & Rachael Levy, The Wall Street Journal
Police officers are prosecuted for murder in less than 2 percent of fatal shootings
German Lopez, Vox
Biden Must Stick to His Pledge to End US Support for the Yemen War
Priyanka Motaparthy & Osamah Alfakih, Just Securit
https://anthraxvaccine.blogspot.com/202 ... l-for.htmlTuesday, December 15, 2020
Drs. Tyson and Fareed's protocol for treatment and prevention of Covid-19, as discussed during Nov 19 Senate hearing
Dr. George Fareed and his partner Dr. Brian Tyson have together successfully treated over 1,000 Covid patients. They have been adjusting their protocol over time, and now use both HCQ and ivermectin. Why not, for a potentially fatal disease? Why not maximize the potential benefit? How many drugs was Trump given when he had Covid?
Here is the protocol provided to the Senate Homeland Security and Government Affairs Committee after Dr. Fareed's Nov 19 testimony.
https://www.thedesertreview.com/news/dr ... 6c181.html Senator Josh Hawley submitted questions to Dr. Fareed to clarify his testimony for the record. Here is the correspondence between the Senator and Fareed on December 10:
Sen. Hawley: In your testimony, you say that timing is everything when it comes to treatment and that the best time for outpatient treatment to prevent hospitalization comes when “the virus is in a period of maximum replication in the upper respiratory tract.” Can you explain what this would mean for a patient? Would this be five days after exposure, or ten days? Or is it based on symptoms?
Dr. Fareed: The earlier the treatment can be started after the start of the infection, the better and more rapid the recovery (as well as the reduction in the risk of spread/contagious period). This would mean that the patient should optimally start the treatment in the first 4 days of the infection and within five days of exposure. It usually is based on symptoms which start within 1-4 days of viral entry into the upper respiratory system. Even starting the multi-faceted treatment later (7-10 days after infection) is also very worthwhile if severe pneumonia necessitating hospitalization has not yet set in.
Sen. Hawley: In your experience, are patients typically coming in to get treated at this point in their illness? And if not, what do you think we need to do to encourage high-risk individuals to seek outpatient treatment and care?
Dr. Fareed: More patients are coming in to get treated or contacting me from afar for treatment when they can’t receive the treatment in their local communities. Sadly, many infected people and primary care doctors and doctors in ERs follow the NIH and Dr. Fauci stipulations with no effective treatments offered. We need to have the NIH/FDA/CDC formally acknowledge the importance of early treatment with moderately acting, safe anti-virals so readily available. When (if ever) that happens, everything would improve dramatically. Thank you, Senator Hawley, for all your efforts and for allowing me to respond to these excellent questions.
The following is the protocol Drs. Fareed and Tyson have jointly developed as most effective for their COVID-19 patients:
Fareed/Tyson COVID-19 Treatment Protocol
HCQ 200 mg tabs #16 (HCQ = hydroxychloroquine)
Zinc sulfate 22O mg (or elemental Zinc 50 mg) # 15
Azithromycin 500 mg # 5 (or Z pack) or
Doxycycline 100 mg # 10)
Ivermectin 3 mg tabs #8
Aspirin 325 mg tabs #30
Day 1 - HCQ 2 tabs twice a day
Zinc sulfate tab twice a day
(Azithromycin tab one per day or doxycycline cap twice a day)
Ivermectin 12 mg on day 1 only
Aspirin 325 mg
Days 2-5
HCQ tab 3 times a day
Zinc sulfate 3 times a day
(Azithromycin tab daily or doxycycline cap twice a day)
Aspirin 325 mg daily
Ivermectin 12 mg on day 3 if symptoms warrant
Prednisone 60 mg daily x 5-7 days or
Dexamethasone 4 mg bid if wheezing /SOB
Budesonide 0.5-1mg/2ml vía nebulizer bid
Vitamin D3 5000 iu daily
Pepcid 20 mg daily
Continue daily Aspirin 325 mg
Over the counter prevention:
Elemental Zinc 25 mg once a day
Vitamin D 4000 iu once a day
Vitamin C 1000 mg once a day
Quercetin 500 mg once a day
If Quercetin is unavailable, then use Epigallocatechin-gallate (EGCG) 400mg once a day
Dr. Fareed also included Dr. Zelenko’s (Twitter: @zev_dr) COVID-19 Prophylaxis Protocol:
Prophylaxis is an action taken to prevent or protect against a specified disease. Greek in origin, from the word "phylax", meaning "to guard" and "watching."
Low Risk Patients
Young healthy people do not need prophylaxis against COVID-19. In young and healthy people, this infection causes mild cold-like symptoms. It is advantageous for these patients to be exposed to COVID-19, build up their antibodies and have their immune system clear the virus. This will facilitate the development of herd immunity and help prevent future COVID-19 pandemics. However, if these patients desire prophylaxis against COVID-19, then they should take the protocol noted below.
Moderate-Risk Patients
Patients from this category are healthy but have high potential viral-load exposure. This group includes medical personnel, caregivers of high-risk patients, people who use public transportation, first responders and other essential personnel who are crucial to the continued functioning of society. These patients should be encouraged to take prophylaxis against COVID-19 in accordance with the protocol noted below.
High-Risk Patients
Patients are considered high risk if they are over the age of 60, or if they are younger than 60 but they have comorbidities, that is, they have other health conditions that put them at risk. These patients have between a 5 to 10 percent mortality rate if they are infected with COVID-19. These patients should be strongly encouraged to take prophylaxis against COVID-19 in accordance with the protocol noted below.
Protocol for Low and Moderate Risk Patients:
Elemental Zinc 25 mg once a day[1]
Vitamin C 1000 mg once a day[2]
Quercetin 500 mg once a day
If Quercetin is unavailable, then use Epigallocatechin-gallate (EGCG) 400 mg once a day[3]
Protocol for High-Risk Patients:
Elemental Zinc 25 mg once a day
Hydroxychloroquine (HCQ[4]) 200 mg once a day for five days, then once a week
If HCQ is unavailable, then use the Protocol for Low and Moderate Risk Patients.
[1]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/
[2]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/
[3]https://pubs.acs.org/doi/10.1021/jf5014633
[4]https://www.preprints.org/manuscript/202007.0025/v1
Posted by Meryl Nass, M.D. at 11:39 PM 0 comments
The spike protein of SARS-CoV-2 (what the mRNA vaccines cause our cells to produce) may be responsible for some of Covid's worst symptoms
This is the most thoughtful and erudite response I have seen to the experiment of turning humans into factories to make Covid (mutated) spike (S) protein. Neither Pfizer, Moderna nor the FDA have commented in any publicly available documents on the serious safety questions this review of the literature raises.
Dr. Patrick Whelan, MD, PhD, formerly of Mass General Hospital and now UCLA, submitted the following letter about the mRNA vaccines to the FDA on December 8:
I am a pediatric specialist caring for children with the multisystem inflammatory syndrome (MIS-C). I am concerned about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein (including the mRNA vaccines of Moderna and Pfizer) have the potential to cause microvascular injury to the brain, heart, liver, and kidneys in a way that does not currently appear to be assessed in safety trials of these potential drugs.
Puntmann et al. (JAMA Cardiol. 2020;5:1265-1273) showed that the prospective study of 100 German patients who were recently recovered from COVID-19 revealed significant cardiac involvement on cardiac MRI scans in 78% of them, an average 2-1/2 months after their recovery from the acute illness. Two-thirds of these patients were never hospitalized, and there was ongoing myocardial inflammation in 60%. The abnormalities occurred independent of preexisting conditions, severity of the initial disease, and overall course of the acute illness.
Magro et al. showed that there is complement-mediated damage even in grossly normal skin of coronavirus-infected individuals (Human Pathology 2020:106:106-116). They have also shown (Magro et al. Annals of Diagnostic Pathology 2021:50 in press ) that ACE-2 receptor expression is highest in the microvasculature of the brain and subcutaneous fat, and to a lesser degree in the liver, kidney, and heart. They have further demonstrated that the coronavirus replicates almost exclusively in the septal capillary endothelial cells of the lungs and the nasopharynx, and that viral lysis and immune destruction of those cells releases viral capsid proteins (or pseudovirions) that travel through the circulation and bind to ACE2 receptors in these other parts of the body leading to mannan-binding lectin complement pathway activation that not only damages the microvascular endothelium but also induces the production of many pro-inflammatory cytokines. Meinhardt et al. (Nature Neuroscience 2020, in press) show that the spike protein in brain endothelial cells is associated with formation of microthrombi (clots), and like Magro et al. do not find viral RNA in brain endothelium. In other words, viral proteins appear to cause tissue damage without actively replicating virus.
Is it possible the spike protein itself causes the tissue damage associated with Covid-19? Nuovo et al (in press) have shown that in 13/13 brains from patients with fatal COVID-19, pseudovirions (spike, envelope, and membrane proteins) without viral RNA are present in the endothelia of cerebral microvessels. Furthermore, tail vein injection of the full length S1 spike subunit in mice led to neurologic signs (increased thirst, stressed behavior) not evident in those injected with the S2 subunit. The S1 subunit localizes to the endothelia of microvessels in the mouse brain, and is a potent neurotoxin. So the spike S1 subunit of SARS-CoV-2 alone is capable of being endocytosed by ACE2 positive endothelia in both human and mouse brain, with a concomitant pauci-cellular microencephalitis that may be the basis for the neurologic complications of COVID-19. The Pfizer/BioNTech vaccine (BNT162b2) is composed of an mRNA that produces a membrane-anchored full-length spike protein. The mouse studies suggest that an untruncated form of the S1 protein like this may cause a microvasculopathy in tissues that express much ACE2 receptor. A truncated form of S1 was much less damaging in mice.
While there are pieces to this puzzle that have yet to be worked out, it appears that the viral spike protein that is the target of the major SARS-CoV-2 vaccines is also one of the key agents causing the damage to distant organs that may include the brain, heart, lung, and kidney. Before any of these vaccines are approved for widespread use in humans, it is important to assess in vaccinated subjects the effects of vaccination on the heart (perhaps using cardiac MRI, as Puntmann et al. did). Vaccinated patients could also be tested for distant tissue damage in deltoid area skin biopsies, as employed by Magro et al. As important as it is to quickly arrest the spread of the virus by immunizing the population, it would be vastly worse if hundreds of millions of people were to suffer long-lasting or even permanent damage to their brain or heart microvasculature as a result of failing to appreciate in the short-term an unintended effect of full-length spike protein-based vaccines on these other organs.
Particular caution will be required with regard to the potential widespread vaccination of children before there are any real data on the safety or effectiveness of these vaccines in pediatric trials that are only now beginning.
Posted by Meryl Nass, M.D. at 5:32 PM 0 comments
